Originally published In Press as doi:10.1074/jbc.M006652200 on August 23, 2000
J. Biol. Chem., Vol. 275, Issue 45, 34887-34893, November 10, 2000
Spatial Regulation and Activity Modulation of Plasmin by High
Affinity Binding to the G domain of the
3 Subunit of
Laminin-5*
Lawrence E.
Goldfinger
§¶,
Luohua
Jiang
§,
Susan B.
Hopkinson
,
M. Sharon
Stack
, and
Jonathan C. R.
Jones
**
From the Departments of
Cell and Molecular Biology
and
Obstetrics and Gynecology, Northwestern University Medical
School, Chicago, Illinois 60611
Received for publication, July 25, 2000, and in revised form, August 17, 2000
 |
ABSTRACT |
Cells in complex tissues contact extracellular
matrix that interacts with integrin receptors to influence gene
expression, proliferation, apoptosis, adhesion, and motility. During
development, tissue remodeling, and tumorigenesis, matrix components
are modified by enzymatic digestion with subsequent effects on integrin
binding and signaling. We are interested in understanding the
mechanisms by which broad spectrum proteinases such as plasmin are
targeted to their extracellular matrix protein substrates. We have
utilized plasmin-mediated cleavage of the epithelial basement membrane glycoprotein laminin-5 as a model to evaluate molecular events that
direct plasmin activity to specific structural domains. We report that
plasminogen and tissue plasminogen activator (tPA) exhibit high
affinity, specific binding to the G1 subdomain of the
N terminus of the laminin-5
3 subunit, with equilibrium
dissociation constants of 50 nM for plasminogen and 80 nM for tPA. No high affinity binding to the G2,
G3, and G4 subdomains was observed. As a result
of binding to the G1 subdomain, the catalytic efficiency of
tPA-catalyzed plasminogen activation is enhanced 32-fold, leading to
increased matrix-associated plasmin that is positioned favorably for
cleavage within the G4 subdomain as we have reported
previously (Goldfinger, L. E., Stack, M. S., and Jones,
J. C. R. (1998) J. Cell Biol. 141, 255-265). Thus, physical constraints dictated by interaction of
proteinase and matrix macromolecule control not only enzymatic activity
but may regulate substrate targeting of proteinases.
 |
INTRODUCTION |
Cells in epithelial tissues are in contact with an array of
extracellular matrix (ECM)1
molecules. Through interaction with cell surface receptors, ECM proteins have a profound influence on gene expression as well as
proliferation, adhesion, and motility (see for example, Refs. 1-4).
During development, tissue remodeling, and tumorigenesis, protein
components of the ECM are often modified by enzymatic digestion (4-9).
Proteolyzed ECM components may bind different cell surface receptors
than their intact counterparts and thereby trigger alternative
signaling events (10). We have utilized plasmin-mediated cleavage of
the epithelial basement membrane glycoprotein laminin-5 as a model to
evaluate molecular events that direct plasmin activity to specific
structural domains.
Laminin-5 secreted by epithelial cells is a heterotrimeric protein with
an
3
3
2 subunit composition
and promotes epithelial cell migration (11, 12). However, we have
previously demonstrated that proteolytic processing of the 190-kDa
3 subunit within the C-terminal globular (G) domain
renders laminin-5 competent to induce formation of hemidesmosomes, cell
matrix anchorage structures formed in part via binding of laminin-5 to
the
6
4 integrin (Fig. 1) (13, 14). As a consequence of
hemidesmosome formation, cellular motility is significantly reduced. In
cultured cells, this functional and structural modification of the
laminin-5
3 subunit occurs as a result of limited
plasmin proteolysis within the G4 subdomain and requires
tissue plasminogen activator (tPA)-catalyzed plasminogen (Pg)
activation (Fig. 1) (14).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic diagram of a laminin-5
heterotrimer. Laminin-5 is a cross-shaped structure composed of
3, 3, and 2 subunits (11,
13). The C-terminal portion of the 3 subunit forms a
compact globular domain, called the G domain, which is divided into
subdomains G1-G5 (16). The putative plasmin
cleavage site in the G4 subdomain, identified by Goldfinger
et al. (14), is indicated by an arrow.
|
|
Both Pg and tPA co-localize with laminin-5 in the ECM of epithelial
cells and bind to intact laminin-5 in vitro (14). Further, previous studies with the laminin-1 isoform demonstrated that Pg and
tPA binding is localized to the G domain at the C terminus of the
laminin
1 subunit (15). Because these data suggest that the G domain of laminin isoforms may function in proteinase targeting, we have evaluated the interaction of Pg and tPA with the G domain of
the
3 subunit of laminin-5. Our results demonstrate high
affinity binding of both Pg and tPA to the G1 subdomain of
the laminin-5
3 subunit. As a functional consequence of
G1 binding, the catalytic efficiency of Pg activation is
enhanced, resulting in increased plasmin activity. These data suggest
that binding of Pg and tPA to the
3 G1
subdomain may function in part to focus cleavage site specificity by
positioning Pg and tPA in close proximity to the processing site within
the G4 subdomain (14).
 |
MATERIALS AND METHODS |
Chemicals, Proteins, and Cloning of
3 Laminin G
Domain Fragments--
Synthetic
D-Val-Leu-Lys-p-nitroanilide (VLK-pNA) was
purchased from Helena Laboratories (Beaumont, TX). The lysine analog
-amino caproic acid (EACA) was purchased from Sigma.
Two-chain recombinant tPA was the generous gift of Dr. Henry Berger
(Wellcome Research Laboratories, Research Triangle Park, NC). Pg was
purified from human plasma by affinity chromatography on
L-lysine-Sepharose. Purified Pg and tPA were biotinylated
by co-incubation with 1 mg/ml N-hydroxy succinimide
biotin at room temperature (Sigma), followed by dialysis against PBS
for 12 h. Biotinylation of the proteins was confirmed by
processing derivatized polypeptides for SDS-PAGE, followed by transfer
to nitrocellulose and Western blotting using a streptavidin-HRP probe
(Life Technologies, Inc., Rockville, MD; see below).
Laminin-5 was a generous gift of Desmos Inc. (San Diego, CA). For
generation of recombinant human laminin
3 subunit G
domain and the G1, G2, G3, and
G4 subdomain proteins, cDNA fragments of 3000, 633, 507, 657, and 553 base pairs, encoding residues 2229-5229, 2374-2907,
2910-3417, 3414-4051, and 4045-4598, respectively, were subcloned by
reverse transcription-polymerase chain reaction from mRNA prepared
from MCF-10A cells (16). Each of these cDNAs was inserted into
either a pET32 or a pBAD-TOPO cloning vector upstream of a sequence
encoding six His residues (Novagen, Inc., Madison, WI and Invitrogen,
Carlsbad, CA). DNA was transfected into BL21(DE3) or LMG bacteria, and
cells containing vector with insert were selected with ampicillin
antibiotic. Expression of recombinant protein was induced with either
isopropylthio-
-D-galactoside or arabinose. To confirm
expression of the appropriate sized recombinant protein, cells were
suspended in gel sample buffer. Protein samples were subjected to
SDS-PAGE and processed for Western blotting by standard procedures
(see below). Recombinant proteins were identified using a His-HRP probe
(Pierce, Rockford, IL). To prepare protein from the bacteria, cells
were extracted in a buffer containing 40 mM imidazole, 4 M NaCl, and 160 mM Tris-HCl, pH 7.9. The
His-tagged proteins were then purified from the cell extracts over a
Ni2+-Sepharose column according to the instructions of the
manufacturer (Novagen). Protein concentrations were determined by
standard Bradford assay (Bio-Rad, Hercules, CA) (17).
SDS-PAGE, Gel Staining, Western Blots, and Ligand
Blots--
Purified laminin-5 and recombinant G domain and subdomain
proteins were solubilized in 8 M urea, 1% SDS sample
buffer in 10 mM Tris-HCl, pH 6.8, with 15%
-mercaptoethanol. Samples were processed for SDS-PAGE on 6-12%
acrylamide gels (18). For silver staining, gels were fixed in 40%
methanol and 10% acetic acid followed by secondary fix in a solution
of 10% ethanol, 5% acetic acid. Proteins were oxidized and silver
stained using reagents from Bio-Rad, according to the instructions of
the manufacturer. In addition, separated proteins were transferred to
nitrocellulose for Western blotting by standard procedures (19).
For ligand blotting, protein was spotted onto nitrocellulose, and the
spot was then allowed to dry. The nitrocellulose was treated with a
blocking buffer (0.1% Tween, 0.9% NaCl, 1 mM
MgCl2, 1 mM dithiothreitol, 0.2% fish gelatin,
0.2% phenylmethylsulfonyl fluoride, in 20 mM Tris, pH 7.4)
for 2 h and then incubated overnight at 4 °C with biotinylated
Pg diluted in the same buffer. After extensive washing the
nitrocellulose was incubated in a streptavidin-HRP conjugate, bound
proteins were detected with ECL chemiluminescent substrate (Amersham
Pharmacia Biotech, Piscataway, NJ), and images were captured on X-Omat
Imaging Film (Eastman Kodak Co., Rochester, NY).
Binding Assay by Surface Plasmon Resonance
Biosensor--
Protein-protein interactions and equilibrium binding
constants were studied by surface plasmon resonance using an IAsys
evanescent wave biosensor (Affinity Sensor, Paramus, NJ). We used
either biotin-coated cuvettes or aminosaline cuvettes, provided by the manufacturer. Streptavidin (100 µg/ml; Sigma) in PBS-0.05%Tween (PBST) was added to the biotin-coated cuvette, and subsequently, either
biotinylated Pg (20 µg/ml) or biotinylated tPA (200 µg/ml) in PBST
was immobilized on the cuvette surface by incubation for approximately
20 min at room temperature. In the case of aminosaline cuvettes, the
cuvette was first washed with 10 mM HCl for 5 min. After
extensive washing with PBS, laminin-5, recombinant G domain, and
subdomains were suspended in PBS at a concentration of 200 µg/ml,
added to the cuvette, and incubated for 30 min at room temperature. The
cuvettes were washed with PBS to remove unbound protein. In all cases,
refraction of the biosensor laser was used as a measure of the affinity
of binding of soluble polypeptides incubated at increasing
concentrations in the cuvette coated with the immobilized protein under
test. All binding experiments were evaluated by nonlinear regression
analysis. All curves fit the equation for a rectangular hyperbola with
a correlation coefficient of 0.97 or greater.
Pg Activation Rate--
Purified laminin-5, recombinant G
domain, and G subdomain proteins were coated at 5 µg/ml in 20 mM HEPES pH 7.4 buffer onto the surfaces of wells of a
96-well plate (Sarsdedt, Arlington Heights, IL) at 4 °C for 14 h. Wells were blocked with 1% BSA for 1 h at 37 °C and then
washed with 20 mM HEPES. The effect of laminin-5 and
recombinant fragments of laminin-5 on the rate of Pg activation was
determined by a coupled reaction in which the amidolytic activity of
generated plasmin was monitored colorimetrically. Pg (0-0.3
µM) was incubated in coated wells for 15 min at 37 °C, followed by addition of 0.3 mM of the plasmin substrate
VLK-pNA at 37 °C in a total volume of 175 µl. Activation of Pg was
initiated by the addition of 0.55 nM tPA (20 IU/ml).
Hydrolysis of VLK-pNA by the resulting plasmin was recorded as a change
in absorbance at 405 nm over time using a Molecular Devices Thermomax
microtiter plate reader (Sunnyvale, CA). Kinetic constants were
extrapolated from the data by nonlinear regression analysis using
Sigmaplot (SPSS Inc., Richmond, CA).
 |
RESULTS |
High Affinity Interaction of Pg and tPA with Laminin-5--
Pg and
tPA are co-localized with laminin-5 in the extracellular matrix of many
epithelial cells, and the presence of both zymogen and activator are
necessary for limited plasmin proteolysis of laminin-5 and subsequent
hemidesmosome assembly (14). Moreover, both purified Pg and tPA have
been shown to interact with laminin-5 in a ligand blot assay (14).
Because plasmin is a broad spectrum proteinase, these results imply
that targeting of cleavage to a distinct domain of the laminin-5
substrate may be regulated by specific protein-protein interactions
that position plasmin in close proximity to its cleavage site. To test
this hypothesis, the affinity of Pg and tPA binding to laminin-5 was
quantified by surface plasmon resonance in an evanescent wave
biosensor. Purified laminin-5 was added stepwise in increasing
concentrations (0-150 nM) to immobilized Pg or tPA, and
the degree of refraction of a light beam crossing the surface of the
immobilized protein was used to measure the affinity of protein-protein
interaction (20, 21). Laminin-5 binds to immobilized Pg and tPA in a
concentration-dependent, saturable fashion with
dissociation constants (Kd) of 40 and 35 nM, respectively (Fig. 2,
A and B). In control experiments, laminin-5 shows
no obvious specific binding to biotinylated control proteins, including
biotinylated BSA (Fig. 2C) and biotinylated lactoperoxidase
(not shown). To confirm the bindings are at equilibrium, in control
experiments, Pg and tPA were coated at approximately half-saturation,
and binding of laminin-5 was evaluated as described above. Although the
plateau of laminin-5 binding was reduced, the overall
Kd for binding was unchanged (not shown). Additional
controls demonstrated that the binding of laminin-5 with Pg was rapid
and reversible (Fig. 3). To mimic more
accurately binding interactions likely to occur in the environment
in vivo, laminin-5 was passively absorbed onto aminosaline
cuvettes and tPA or Pg binding was evaluated as described above. These
data confirmed concentration-dependent, saturable binding
between Pg or tPA and laminin-5 with dissociation constants
(Kd) of 25 and 40 nM, respectively (Fig.
2, D and E). Soluble uPA failed to bind
immobilized laminin-5, confirming the specificity of tPA and Pg binding
to laminin-5 (Fig. 2F).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Pg and tPA bind to laminin-5.
Biotinylated Pg (A), tPA (B), or BSA
(C) was immobilized on the surface of streptavidin-coated
cuvettes in saturating amounts. Soluble laminin-5 was added at
concentrations (Conc.) in the range of 0-150
nM. In the reverse experiments (D-F), binding
of Pg (D), tPA (E), or uPA (F) to
immobilized laminin-5 was evaluated. In this and all subsequent protein
binding assays, the level of binding was measured by surface plasmon
resonance in an IAsys evanescent wave biosensor. Kd
values were calculated by determining the concentration of protein
required for half-maximal binding at equilibrium and are indicated in
the figure.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Kinetics and reversibility of laminin-5 and
Pg interaction. Binding of laminin-5 to immobilized Pg was
initiated by the addition of 400 nM laminin-5 into the
cuvettes, and the binding was monitored using surface plasmon
resonance. Dissociation was induced by replacing laminin-5 solution
with blank buffer.
|
|
Binding Site Localization of Pg and tPA on the
3 Subunit of Laminin-5--
To investigate whether Pg
and tPA binding sites are localized proximal to the plasmin cleavage
site in the G domain of the
3 subunit of the laminin-5
molecule (Fig. 1), binding to recombinant G domain and subdomain
polypeptides was also evaluated. Sequences corresponding to the entire
laminin-5 G domain or the individual G1, G2,
G3, and G4 subdomains were generated from
MCF-10A cell mRNA by reverse transcription-polymerase chain
reaction and then cloned into bacteria expression vectors. The latter
were transfected into bacterial cells and recombinant proteins with a
C-terminal His6 tag were purified from cell lysates over a
Ni2+-Sepharose column. Protein recovery was typically
approximately 1 mg of purified protein/liter of induced bacterial
culture. Purity of recombinant proteins was confirmed by silver
staining following separation by SDS-PAGE (Fig.
4). These same polypeptides are
recognized by a His-HRP probe (results not shown). Surface plasmon
resonance binding experiments were then performed with the recombinant
3 subdomain polypeptides. Similar to intact laminin-5,
both Pg and tPA bound to immobilized
3 laminin G domain
in a concentration-dependent and saturable manner
(Kd = 12 and 10 nM, respectively; Fig.
5). In the reverse experiment,
recombinant G domain bound to immobilized Pg or tPA with similar
affinities (Kd = 2 and 4 nM,
respectively) (not shown). Similar Kd values were
obtained when Pg or tPA were immobilized at half-saturation concentration (not shown).

View larger version (97K):
[in this window]
[in a new window]
|
Fig. 4.
Purity of recombinant G domain proteins.
Recombinant His-tagged human laminin 3 subunit G domain
and the G1, G2, G3, and
G4 subdomain proteins were purified over a
Ni2+-Sepharose column following expression in bacteria.
Samples of the pure protein fractions were solubilized in gel sample
buffer and subjected to SDS-PAGE. Gels were subsequently fixed and
stained with silver reagent. Recombinant whole G domain and
G1, G2, G3, and G4
subdomain proteins migrate at 95, 35, 38, 30, and 28 kDa, respectively.
Molecular markers are indicated to the left.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Pg and tPA bind to the G domain of the
3 subunit of laminin-5. Pg or tPA
(0-50 nM) was added to immobilized recombinant
3 G domain protein and binding evaluated by surface
plasmon resonance as described under "Materials and Methods."
|
|
Because these results demonstrated high affinity of Pg and tPA binding
to the
3 G domain, interaction specificity was further delineated using recombinant G1, G2,
G3, and G4 subdomain polypeptides. Pg and tPA
bind to immobilized G1 with a Kd of 50 and 80 nM, respectively (Fig.
6, A and B).
Conversely, when tPA and Pg are immobilized at saturated or
half-saturated level, the respective Kd (25 and 40 nM for Pg and tPA, respectively) for the binding of
purified G1 to these proteins are comparable (not shown). Pg and tPA showed little binding to immobilized G4 (Fig. 6,
C and D). In additional experiments, no binding
of Pg or tPA to purified recombinant G2 or G3
subdomain proteins was observed (not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Pg and tPA bind to the G1
subdomain of the 3 subunit of
laminin-5. Pg or tPA (0-100 nM) was added to
immobilized recombinant 3 G1 (A
and B) or G4 (C and D)
subdomain protein and binding evaluated by surface plasmon resonance as
described under "Materials and Methods."
|
|
Pg has been shown to bind to matrix molecules via interaction with
lysine residues (22). To determine whether Pg interacts with the
G1 subdomain in a lysine-dependent manner,
G1 subdomain protein and, as a control, G4
subdomain protein were spotted onto nitrocellulose at 1 µg/ml and
incubated with purified biotinylated Pg at 10 µg/ml. Pg bound
G1 but not G4 protein, consistent with results
presented above. The lysine analog, EACA, inhibited Pg binding to the
G1 protein (Fig.
7A). These results were
confirmed using surface plasmon resonance, where binding interactions
between laminin-5, G domain, or G1 subdomain with Pg were
effectively blocked by EACA (Fig. 7B).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Pg binding to the G1 subdomain of
the laminin-5 3 subunit is
lysine-dependent. A, recombinant
G1 or G4 subdomain (1 µg/ml) protein was
spotted onto nitrocellulose and incubated with biotinylated Pg in the
presence or absence of the lysine analog -amino caproic acid as
indicated. Bound Pg was detected with streptavidin-HRP. B,
effect of EACA on binding of Pg to immobilized laminin-5 and its
3 subdomains. Binding of Pg (400 nM) to
immobilized laminin-5, recombinant 3 G, G1,
or G4 polypeptides in the presence or absence of EACA (50 mM, as indicated) was evaluated as described by surface
plasmon resonance as described under "Materials and Methods."
|
|
Pg Activation in the Presence of Recombinant G Domain
Proteins--
Specific localization of Pg and tPA to the
G1 subdomain of laminin-5 may direct subsequent proteolysis
within the G4 subdomain (14). In addition to substrate
targeting, proteinase binding to immobilized matrix may also influence
zymogen activation kinetics (23). This is supported by the observation
that both Pg and tPA bind to the same
3 G subdomain. To
evaluate the effect of laminin-5 binding on Pg activation kinetics, tPA
catalyzed Pg activation was evaluated in the presence of immobilized G
domain or subdomain polypeptides. Michaelis-Menten
curves for the activation reactions are
shown in Fig. 8, and kinetic constants
are summarized in Table I. Whereas
activation on G2, G3, or G4
subdomain coated surfaces was similar to that observed in
solution, activation on G1 was significantly enhanced (by a
32 folds increase in Kcat/Km). These data suggest
that colocalization of Pg and tPA to laminin-5 containing matrix
surfaces via interaction with the
3 G1
subdomain may result in increased concentration of plasmin properly
positioned laminin-5 processing.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of laminin-5
3 G subdomain fragments on
tPA-catalyzed Pg activation kinetics. Micro-titer wells coated
with recombinant G1, G2, G3, or
G4 subdomain proteins were preincubated with Pg (0-0.3
µM) 15 min at 37 °C followed by addition of VLK-pNA
(0.3 mM) and tPA (0.55 nM). The resulting
hydrolysis of VLK-pNA by plasmin was monitored at 405 nm. Control
reactions were performed on wells coated with albumin to correct for
nonspecific effects of protein-protein interactions. Activation
velocity (mol plasmin generated/min) on surfaces coated with
recombinant subdomain proteins or albumin are indicated as follows:
G1 ( ), G2 ( ), G3 ( ),
G4 ( ), and albumin ( ). Lines drawn
represent predicted fit of the data points to a rectangular hyperbola.
Kinetic constants were calculated by nonlinear regression analysis and
are summarized in Table I.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters of Pg activation by tPA in the presence of
recombinant laminin-5 subdomain fragments
Kinetic constants were determined from the initial velocity data shown
in Fig. 8 using nonlinear regression analysis. Fold change in catalytic
efficiency (Kcat/Km) is expressed
relative to control reactions on albumin-coated wells.
|
|
 |
DISCUSSION |
Laminin G domains contain binding sites for cells and other ECM
molecules and thus contribute significantly to laminin function. The G
domains of both the
1 and
2 laminin
subunits have high affinity binding sites for a variety of
extracellular matrix molecules such as perlecan, heparin, and
sulfatides, as well as for cell surface receptors including
-dystroglycan (24-26). Fibulin-1 and -2 and nidogen-2 also bind to
the laminin
2 G domain but with somewhat lower affinity
(26). In the case of laminin-5, the
3
1
integrin binding site has been reported to lie within the G2 subdomain, whereas laminin-5 apparently interacts with
heparin and other macromolecules via its G4 and
G5 subdomains (27). In this study we have demonstrated that
both Pg and tPA bind specifically and with high affinity to the
G1 subdomain, the first proximal region of the laminin-5
3 chain G domain. The functional significance of these
interactions is apparent, because we have previously shown that plasmin
cleavage of laminin-5 has a profound impact on epithelial cell
behavior (14).
The G1 subdomain of the laminin
3 subunit
shows little homology with the corresponding domains of the
1 and
2 laminin subunits (16, 28, 29),
and in previous studies no binding of Pg or tPA to the
1
G1 subdomain was observed (15). Indeed, Pg and tPA appear
to bind the laminin
1 G4 domain, whereas we
detect no such binding to the analogous domain of the
3
laminin subunit (15). The G1 subdomain of the laminin
3 subunit shows 58% similarity with that of the laminin
4 chain and 53% similarity to that of the human laminin
5 chain (16, 30-32), raising the possibility that the
subunit G1 domains of other laminin isoforms may also bind Pg and tPA. Further, the G4 subdomain of the human
3 chain, which contains the plasmin cleavage site we
have identified previously, has 53% similarity to that of the human
4 laminin chain, suggesting that the
4
chain may also be subject to plasmin proteolytic processing (14, 16,
30).
Our data support the idea that Pg binds the laminin
3
subunit G1 subdomain in a lysine-dependent
manner. Lysine binding site-dependent association of Pg
with fibrin or other matrix molecules induces a dramatic conformational
change in Pg, resulting in a 15 Å increase in its Stoke's radius. As
a result of this conformational change, the
Arg561-Val562 peptide bond is more readily
accessible to tPA, thus enhancing the catalytic efficiency of the
activation (23, 33, 34). In the current study, a significant increase
in kcat/Km is observed in
following Pg and tPA interaction with either intact G domain or
G1 subdomain. Taken together, our data suggest a model for the regulation of plasmin cleavage of laminin-5. High affinity association of Pg and tPA with the G1 subdomain of intact
laminin-5 enhances the catalytic efficiency of tPA-catalyzed Pg
activation, resulting in generation of plasmin. Because recent data
suggest a close association of the G1 and G4
subdomains in intact laminin, the newly generated plasmin is thus
properly positioned for proteolytic cleavage within the G4
subdomain (Fig. 1) (14, 35). Interestingly, there is a precedent for
this because it has been shown previously that in endothelial cells, Pg
and tPA bind the annexin II tetramer, a calcium- and
phospholipid-binding protein, with high affinity (36, 37). Moreover,
the formation of the Pg, tPA, and annexin II complex facilitates
tPA-dependent conversion of Pg to plasmin (38-40).
Unprocessed laminin-5 in the extracellular matrix promotes migration of
epithelial cells, whereas plasmin-cleaved laminin-5 blocks cell
migration by inducing formation of hemidesmosomes, which anchor the
cells to the cleaved laminin-5 substrate (14). Therefore, the ability
of cells to efficiently generate plasmin and to specifically localize
the enzyme to a distinct subdomain of the 460-kDa macromolecular
laminin-5 substrate may represent key regulatory steps that control the
divergent cell processes of migration and adhesion (14).
 |
ACKNOWLEDGEMENTS |
We thank Dr. Katharina Spiegel of the Keck
Biophysics Facility, Northwestern University, for invaluable help in
the use of equipment and interpretation of results. We are very
grateful for the assistance of Meredith Gonzales and Bob Valadka in
preparing the figures.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant RO1 GM38470 (to J. C. R. J.) and by the NIDR,
National Institutes of Health Grant PO1 DE12328 (to J. C. R. J. and M. S. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
Supported by an NCI training grant (T32 CA09560).
**
To whom to address correspondence: Cell and Molecular Biology,
Morton 4-616, Northwestern University Medical School, 303 E. Chicago
Ave., Chicago, IL 60611. Tel.: 312-503-1412; Fax: 312-503-6475; E-mail:
j-jones3@nwu.edu.
Published, JBC Papers in Press, August 23, 2000, DOI 10.1074/jbc.M006652200
 |
ABBREVIATIONS |
The abbreviations used are:
ECM, extracellular
matrix;
tPA, tissue plasminogen activator;
Pg, plasminogen;
VLK-pNA, D-Val-Leu-Lys-p-nitroanilide;
EACA,
-amino
caproic acid;
PBS, phosphate-buffered saline;
PAGE, polyacrylamide gel
electrophoresis;
HRP, horseradish peroxidase;
BSA, bovine serum
albumin.
 |
REFERENCES |
| 1.
|
Blaschke, R. J.,
Howlett, A. R.,
Desprez, P. Y.,
Petersen, O. W.,
and Bissell, M. J.
(1994)
Methods Enzymol.
245,
535-556
|
| 2.
|
Yamada, K. M.,
and Miyamoto, S.
(1995)
Curr. Opin. Cell Biol.
7,
681-689
|
| 3.
|
Boudreau, N.,
and Bissell, M. J.
(1998)
Curr. Opin. Cell Biol.
10,
640-646
|
| 4.
|
Lukashev, M. E.,
and Werb, Z.
(1998)
Trends Cell Biol.
8,
437-441
|
| 5.
|
Ashkenas, J.,
Muschler, J.,
and Bissell, M. J.
(1996)
Dev. Biol.
180,
433-444
|
| 6.
|
Reich, E.
(1978)
in
Biological Markers of Neoplasia: Basic and Applied Aspects
(Ruddon, R. W., ed)
, pp. 506-512, Elsevier, Amsterdam
|
| 7.
|
Highsmith, R. F.
(1981)
J. Biol. Chem.
256,
6788-6795
|
| 8.
|
Ossowski, L.,
and Vassalli, J. D.
(1978)
in
Biological Markers of Neoplasia: Basic and Applied Aspects
(Ruddon, R. W., ed)
, pp. 473-479, Elsevier, Amsterdam
|
| 9.
|
Strickland, S.,
Reich, E.,
and Sherman, M. I.
(1976)
Cell
9,
231-240
|
| 10.
|
Werb, Z.
(1997)
Cell
91,
439-442
|
| 11.
|
Rousselle, P.,
Lunstrum, G. P.,
Keene, D. R.,
and Burgeson, R. E.
(1991)
J. Cell Biol.
114,
567-576
|
| 12.
|
Zhang, K.,
and Kramer, R.
(1996)
Exp. Cell Res.
227,
309-333
|
| 13.
|
Baker, S. E.,
Hopkinson, S. B.,
Fitchmun, M.,
Andreason, G. L.,
Frasier, F.,
Plopper, G.,
Quaranta, V.,
and Jones, J. C. R.
(1996)
J. Cell Sci.
109,
2509-2520
|
| 14.
|
Goldfinger, L. E.,
Stack, M. S.,
and Jones, J. C. R.
(1998)
J. Cell Biol.
141,
255-265
|
| 15.
|
Moser, T. L.,
Enghild, J. J.,
Pizzo, S. V.,
and Stack, M. S.
(1993)
J. Biol. Chem.
268,
18917-18923
|
| 16.
|
Ryan, M. C.,
Tizard, R.,
VanDevanter, D. R.,
and Carter, W. G.
(1994)
J. Biol. Chem.
269,
22779-22787
|
| 17.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 18.
|
Laemmli, U. K.
(1970)
Nature
277,
680-685
|
| 19.
|
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, pp. 92-121, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 20.
|
Jönsson, U.,
and Malmqvist, M.
(1992)
Adv. Biosensors
2,
291-336
|
| 21.
|
Gase, K.,
Gase, A.,
Schirmer, H.,
and Malke, H.
(1996)
Eur. J. Biochem.
239,
42-51
|
| 22.
|
Stack, M. S.,
Madison, E. L.,
and Pizzo, S. V.
(1995)
in
Molecular Basis of Thrombosis and Hemostasis
(High, K. A.
, and Roberts, H. R., eds)
, pp. 479-494, Marcel Dekker, Inc., New York
|
| 23.
|
Stack, M. S.,
Gonzales-Gronow, M.,
and Pizzo, S. V.
(1990)
Biochemistry
30,
2073-2077
|
| 24.
|
Yurchenco, P. D.,
Sung, U.,
Ward, M. D.,
Yamada, Y.,
and O'Rear, J. J.
(1993)
J. Biol. Chem.
268,
8356-8365
|
| 25.
|
Sung, U.,
O'Rear, J. J.,
and Yurchenco, P. D.
(1997)
Eur. J. Biochem.
250,
138-143
|
| 26.
|
Talts, J. F.,
Andac, Z.,
Gohring, W.,
Brancaccio, A.,
and Timpl, R.
(1999)
EMBO J.
18,
863-870
|
| 27.
|
Mizushima, H.,
Takamura, H.,
Miyagi, Y.,
Kikkawa, Y.,
Yamanaka, N.,
Yasumitsu, H.,
Misugi, K.,
and Miyazaki, K.
(1997)
Cell Growth Differ.
8,
979-987
|
| 28.
|
Sasaki, M.,
Kleinman, H. K.,
Huber, H.,
Deutzmann, R.,
and Yamada, Y.
(1988)
J. Biol. Chem.
263,
16536-16544
|
| 29.
|
Vuolteenaho, R.,
Nissinen, M.,
Sainio, K.,
Byers, M.,
Eddy, R.,
Hirvonen, H.,
Shows, T. B.,
Sariola, H.,
Engvall, E.,
and Tryggvason, K.
(1994)
J. Cell Biol.
124,
381-394
|
| 30.
|
Iivanainen, A.,
Sainio, K.,
Sariola, H.,
and Tryggvason, K.
(1995)
FEBS Lett.
365,
183-188
|
| 31.
|
Miner, J. H.,
Lewis, R. M.,
and Sanes, J. R.
(1995)
J. Biol. Chem.
270,
28523-28526
|
| 32.
|
Frieser, M.,
Nöckel, H.,
Pausch, F.,
Röder, C.,
Hahn, A.,
Deutzmann, R.,
and Sorokin, L. M.
(1997)
Eur. J. Biochem.
246,
727-735
|
| 33.
|
Castellino, F. J.
(1981)
Chem. Rev.
81,
431-436
|
| 34.
|
Mangel, W., BH., L.,
and Ramakrishnan, V.
(1990)
Science
248,
69-73
|
| 35.
|
Andac, Z.,
Sasaki, T.,
Mann, K.,
Brancaccio, A.,
Deutzmann, R.,
and Timpl, R.
(1999)
J. Mol. Biol.
287,
253-64
|
| 36.
|
Hajjar, K. A.,
Jacovina, A. T.,
and Chacko, J.
(1994)
J. Biol. Chem.
269,
21191-21197
|
| 37.
|
Hajjar, K. A.,
Mauri, L.,
Jacovina, A. T.,
Zhong, F.,
Mirza, U. A.,
Padovan, J. C.,
and Chait, B. T.
(1998)
J. Biol. Chem.
273,
9987-9993
|
| 38.
|
Kassam, G.,
Le, B.-H.,
Choi, K.-S.,
Kang, H.-M.,
Fitzpatrick, S. L.,
Louie, P.,
and Waisman, D. M.
(1998)
Biochemistry
37,
16958-16966
|
| 39.
|
Cesarman, G. M.,
Guevara, C. A.,
and Hajjar, K. A.
(1994)
J. Biol. Chem.
269,
21198-21203
|
| 40.
|
Kassam, G.,
Choi, K.-S.,
Ghuman, J.,
Kang, H.-M.,
Fitzpatrick, S. L.,
Zackson, T.,
Zackson, S.,
Toba, M.,
Shinomiya, A.,
and Waisman, D. M.
(1998)
J. Biol. Chem.
273,
4790-4799
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Ito, T. Nagai, H. Kamei, N. Nakamichi, T. Nabeshima, K. Takuma, and K. Yamada
Involvement of Tissue Plasminogen Activator-Plasmin System in Depolarization-Evoked Dopamine Release in the Nucleus Accumbens of Mice
Mol. Pharmacol.,
November 1, 2006;
70(5):
1720 - 1725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nagai, K. Yamada, M. Yoshimura, K. Ishikawa, Y. Miyamoto, K. Hashimoto, Y. Noda, A. Nitta, and T. Nabeshima
From The Cover: The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release
PNAS,
March 9, 2004;
101(10):
3650 - 3655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Hoffman, J. A. Engbring, P. K. Nielsen, J. Vargas, Z. Steinberg, A. J. Karmand, M. Nomizu, Y. Yamada, and H. K. Kleinman
Cell Type-specific Differences in Glycosaminoglycans Modulate the Biological Activity of a Heparin-binding Peptide (RKRLQVQLSIRT) from the G Domain of the Laminin alpha 1 Chain
J. Biol. Chem.,
June 15, 2001;
276(25):
22077 - 22085.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.